A股化纤板块震荡走高，桐昆股份涨停，新凤鸣、泰和新材、荣盛石化、恒逸石化等涨幅居前。

The FDA has approved Revolution Medicines' pancreatic cancer drug Daraxonrasib, which will be marketed as Rasonque. The drug is the first therapy targeting one of the disease's key molecular pathogenic mechanisms. A late-stage trial published in May showed Daraxonrasib nearly doubled typical survival in an aggressive form of pancreatic cancer to 13.2 months versus 6.7 months with chemotherapy, the current standard of care.

财报公布后，英伟达(NVDA.O)盘后一度跌近3%。